IsoPlexis Corp

IsoPlexis Corp (ISO) priced its initial public offering on Oct 12, 2021 at $15.00 per share, raising $125M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $582.7M. Morgan Stanley was lead-left underwriter, joined by TD Cowen and Evercore ISI. Cravath advised the company and Latham & Watkins advised the underwriters.

IsoPlexis Corp provides a single cell proteomics platform of instruments, chip consumables and software. It combines proteomics and single cell biology to show protein function at the level of individual cells, linking cellular function to treatment response and disease progression.

Status

IPO

Ticker

ISO

Exchange

Nasdaq Global Select

Priced

Oct 12, 2021

IPO price

$15.00

Raised

$125M

Market cap at IPO price

$582.7M

First filed

Jul 20, 2021

Underwriters

Morgan Stanley, TD Cowen and Evercore ISI

Company counsel

Cravath

Underwriters' counsel

Latham & Watkins

Sector

Industrials & materials

Country / state

CT

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.